Last updated: 2026-09-04 14:47:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Sana Biotechnology, Inc. (SANA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3.87, with a market capitalization of $1.16B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.61 to $6.55. This page covers its latest market performance, valuation, price trends and company information.
$1.16B | |
$3.86 | |
$44.60 | |
$1.26 | |
$3.92 | |
249.75K | |
-- | |
-- | |
$6.55 | |
$2.61 | |
-- | |
-- |
Sana Biotechnology, Inc. (SANA) is currently trading at $3.87 as of 2026-09-04 14:30:19, down 1.40% ($0.05) from the previous close of $3.92
During today's regular trading session, SANA has traded between $1.26 and $44.60, with a trading volume of 249.75K shares. The current price is near the lower end of today's range.
Over the past seven days, Sana Biotechnology, Inc. (SANA) moved from $3.87 to $3.87, representing a decline of 0.13% ($0.00).
The stock traded between $3.81 and $3.96 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 1.83 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 31.9%
SANA is currently trading at $3.87, placing it 31.9% of the way from its 52-week low of $2.61 to its 52-week high of $6.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 142 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sana Biotechnology, Inc. (SANA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.